REBOXETINE for Schizoaffective disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where REBOXETINE was used for Schizoaffective disorder.
Most Reported Side Effects for REBOXETINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperhidrosis | 21 | 11.4% | 0 | 0 |
| Off label use | 20 | 10.8% | 0 | 1 |
| Weight increased | 18 | 9.7% | 0 | 0 |
| Tachycardia | 17 | 9.2% | 2 | 2 |
| Confusional state | 16 | 8.7% | 2 | 9 |
| Intentional overdose | 16 | 8.7% | 2 | 10 |
| Nausea | 16 | 8.7% | 1 | 6 |
| Drug ineffective | 15 | 8.1% | 0 | 9 |
| Drug interaction | 15 | 8.1% | 0 | 5 |
| Sleep disorder | 15 | 8.1% | 0 | 3 |
| Alanine aminotransferase increased | 14 | 7.6% | 0 | 1 |
| Depression | 14 | 7.6% | 0 | 4 |
| Dizziness | 14 | 7.6% | 0 | 1 |
| Oedema peripheral | 14 | 7.6% | 0 | 0 |
| Therapeutic product effect incomplete | 14 | 7.6% | 0 | 0 |
Other Indications for REBOXETINE
Product used for unknown indication (64)
Depression (62)
Bipolar disorder (11)
Antidepressant therapy (7)
Major depression (6)
Schizophrenia (6)
Drug abuse (5)
Other Drugs Used for Schizoaffective disorder
CLOZAPINE (2,553)
PALIPERIDONE (2,001)
RISPERIDONE (1,776)
ARIPIPRAZOLE (1,720)
OLANZAPINE (1,035)
QUETIAPINE (890)
LITHIUM (484)
HALOPERIDOL (285)
LURASIDONE (282)
VALPROIC ACID (250)